Jazz Pharmaceuticals plc (JAZZ) Shareholders’ equity 2016–2025
Jazz Pharmaceuticals plc (JAZZ) shareholders’ equity at each fiscal year-end, per SEC filings.
$4.3BFY2025 · since FY2016: $1.9B → $4.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.3B | +5.5% |
| FY2024 | $4.1B | +9.5% |
| FY2023 | $3.7B | +21.1% |
| FY2022 | $3.1B | -22.2% |
| FY2021 | $4.0B | +8.3% |
| FY2020 | $3.7B | +17.6% |
| FY2019 | $3.1B | +12.8% |
| FY2018 | $2.8B | +1.6% |
| FY2017 | $2.7B | +44.5% |
| FY2016 | $1.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice